Urges Biden Administration to lift regulatory freeze on executive orders designed to reduce cost of life-saving prescription drugs for Americans.

This resolution (SR 18) urges the Biden Administration to lift its regulatory freeze on four 2020 executive orders issued by President Trump aimed at lowering prescription drug costs. The orders targeted life-saving medications like insulin and epinephrine, seeking to end "kickback" systems that increase costs, require health centers to pass drug discounts directly to patients, and allow safe importation of drugs from Canada where prices are lower. The resolution states these policies would benefit millions of Americans, particularly seniors, the uninsured, and low-income patients struggling with high drug prices. It does not create new law but formally requests the administration implement these specific Trump-era policies.